oral glp 1 medication Is the Wegovy® Pill & Other GLP-1s Worth the Wait? GLP-1 Medications and Dry Mouth:

Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models

And this week they published a report outlining their findings: Title: Diabetes medications and risk of Parkinsons disease: a cohort study of patients with diabetes Authors: Brauer R, Wei L, Ma T, Athauda D, Girges C, Vijiaratnam N, Auld G, Whittlesea C, Wong I, Foltynie T

Gastrointestinal symptoms during dose changes Nausea, constipation, and other GI symptoms are the most common side effects of GLP-1 therapy, and they tend to re-emerge whenever dosing changes occur

Step three: combination and intensification For patients who do not reach their targets on either medication alone, combining basal insulin with a GLP-1 agonist is an increasingly popular strategy

Treatments for Obesity Two GLP-1 RAs (semaglutide and liraglutide) have also been approved for the treatment of obesity